Apolipoprotein A (APOA) ELISA Kits

The protein encoded by APOA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. Additionally we are shipping Apolipoprotein A Antibodies (47) and Apolipoprotein A Proteins (3) and many more products for this protein.

list all ELISA KIts Gene Name GeneID
APOA 4018
APOA 709528
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top Apolipoprotein A ELISA Kits at antibodies-online.com

Showing 6 out of 9 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Human 1.48 ng/mL 3.12 ng/mL - 200 ng/mL 96 Tests 13 to 16 Days
Monkey 15.63 ng/mL 31.25-2000 ng/mL Typical standard curve 96 Tests 15 to 18 Days
Human 0.08 ng/mL 0.08-20 ng/mL 96 Tests 2 to 3 Days
Mouse 0.938 ng/mL 1.56 ng/mL - 100 ng/mL A typical standard curve 96 Tests 13 to 16 Days
Rat 0.938 ng/mL 1.56 ng/mL - 100 ng/mL A typical standard curve 96 Tests 13 to 16 Days
Human 0.008 ng/mL n/a   96 Tests 11 to 16 Days

Top referenced Apolipoprotein A ELISA Kits

  1. Human APOA ELISA Kit for Sandwich ELISA - ABIN416773 : Liu, Du, Cong, Jia, Yang: Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease. in Evidence-based complementary and alternative medicine : eCAM 2016 (PubMed)
    Show all 2 Pubmed References

  2. Human APOA ELISA Kit for Sandwich ELISA - ABIN2345022 : Bissig-Choisat, Wang, Legras, Saha, Chen, Bell, Pankowicz, Hill, Barzi, Leyton, Leung, Kruse, Himes, Goss, Wilson, Chan, Lagor, Bissig: Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. in Nature communications 2015 (PubMed)

More ELISA Kits for Apolipoprotein A Interaction Partners

Human Apolipoprotein A (APOA) interaction partners

  1. Elevated serum lipoprotein(a) level is an independent predictor of cardiac and cardiovascular events in the coronary artery disease patients.[meta-analysis]

  2. We show that PCSK9 levels increase with age in ART children, indicating a gradual deterioration of lipidemic profile that could lead to increased cardiovascular risk. Moreover, our results indicate that ART method may be of importance given that classic IVF is associated with higher levels of Lp(a).

  3. Lp(a) was only a marker for coronary artery disease in patients with familial hypercholesterolemia.

  4. Circulating Lp(a) is not prospectively associated with future venous thromboembolism risk.

  5. Stable outpatients with symptomatic artery disease and Lp(a) levels >30mg/dL were at a 5-fold higher risk for subsequent myocardial infarction, stroke or limb amputation. Those with levels >50mg/dL were at an over 10-fold higher risk.

  6. In patients with potential familial hypercholesterolemia, positive correlations between concentrations of Lp(a) and PCSK9, as well as of Lp(a)-PCSK9 plasma complex with large subfractions of intermediate and low-density lipoproteins (IDL-1 and LDL-C), were determined by the low molecular weight apo(a) phenotype.

  7. Lp(a) concentration, but not apo(a) isoform size, is independently associated with angiographic extent and severity of coronary artery disease, but not carotid artery plaque.

  8. potential role for Lp(a) as a possible risk marker useful to stratify, among bicuspid aortic valve stenosis patients

  9. Lp(a) molar/mass ratios are threshold, method, and isoform dependent

  10. Meta-analysis: Genetic variations at the LPA locus are associated with CHD events during statin therapy independently of the extent of low-density lipoprotein cholesterol lowering.

  11. Lp(a) accelerates progression of atherosclerosis in these individuals, thereby contributing to their increased ASCVD risk

  12. Proinflammatory interleukin 1 (IL-1(+)) genotypes modulate the risk of Lp(a) long-term cardiovascular disease (CVD) events and coronary artery disease (CAD).

  13. The autors results confirm the association between LPA SNPs rs10455872 and rs3798220 with AS and demonstrated that individuals with 2 risk alleles have a 2-fold or greater odds of developing AS.

  14. The LPA 9p21 locus was associated with risk of aortic valve stenosis.

  15. High lipoprotein(a) levels were associated with a higher incidence of major adverse limb events after endovascular treatment for patients with aortoiliac lesions.

  16. In a multiethnic sample, Lp(a)-related risks of heart failure were only evident in white participants.

  17. High plasma lipoprotein a levels accelerated the progression of atherosclerosis in end-stage renal disease through lipoprotein a accumulation in the arteries.

  18. The population differences in Lp(a) concentrations between Finnish and Central European populations originate not only from a different LPA isoform distribution but suggest the existence of novel functional variation in the small-isoform range.

  19. Elevated lipoprotein(a) concentrations were independently associated with an increased risk of abdominal aortic aneurysms.

  20. Lp(a) seems to be an independent risk factor for acute coronary syndromes in individuals <45 years, and high Lp(a) levels increase by approximately 3folds the risk for ACS. The association is preserved but is less in middle-aged individuals (45-60 years) and is abolished >60 years.

Apolipoprotein A (APOA) Antigen Profile

Antigen Summary

The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence.

Gene names and symbols associated with Apolipoprotein A (APOA) ELISA Kits

  • lipoprotein(a) (LPA) antibody
  • AK38 antibody
  • Apo(a) antibody
  • APOA antibody
  • LP antibody
  • Lp(a) antibody

Protein level used designations for Apolipoprotein A (APOA) ELISA Kits

antiangiogenic AK38 protein , apo(a) , apolipoprotein(a) , lp(a)

4018 Homo sapiens
709528 Macaca mulatta
Selected quality suppliers for Apolipoprotein A (APOA) ELISA Kits
Did you look for something else?